Although veterinarians are often skilled at diagnosing pets with clinical heart failure, it is critical they are skilled at diagnosing those with pre-clinical heart disease as well, according to Amara Estrada, DVM, DACVIM(Cardiology), professor of cardiology at the University of Florida. This proactive approach positively impacts patients by enhancing their quality of life and ultimately helping to delay the disease's development.
At the 2021 New York Vet Show in New York, New York, Estrada shared the various benefits of the “ABCD” classification system, plus she outlined each stage.
The benefits of the ABCD classification system
Classifying each stage of heart disease in pets helps with the following:
- Development of screening programs for at-risk breeds
- Implementation of an intervention that decreases the diseases’ risk of development or progression
- Early identification of asymptomatic patients
- Quicker, more confident identification of symptomatic patients
- Communication among veterinarians and with clients as you gain an understanding of where in the timeline the patient is
The ABCD classification system
Although the first several stages (A-B2) consist of preclinical heart disease and are when it is key to step in and take initiative, the final 2 stages (C-D) include the clinical phases of heart failure.
Stage A
During this first stage, the pet appears healthy and there is no structural disease, but they are at high risk for developing heart disease because of their breed—some at-risk dog and cat breeds Estrada noted include Doberman pinschers, cavalier King Charles spaniels, and Maine coons.
“Stage A, this is pets that have nothing wrong with them, you don’t find anything on the physical exam, but they’re kind of the poster child for heart disease in the veterinary world,” she explained.
There are genetic tests available for heart disease that allow pets to be tested as early as in puppyhood which Estrada said is a great time to begin. Although this will likely not change the course of the disease, you can confirm if mutations are present and establish with the owner that earlier screenings are advised for their predisposed pet.
Stage B1 and B2
Stage B1 is classified by asymptomatic disease with none to minimal remodeling present yet something abnormal appears on the physical exam, which then should prompt you to stage the disease, according to Estrada.
“The reason I have to stage it is because I’m trying to decide: is [the dog] very, very early in the course of his disease where [it’s] a B1 and [it] doesn’t have any structural remodeling, or is [the dog] at the phase where he’s a B2 and I now have clinical trial evidence that tells me if I start to treat X at this stage B2, I will make an extreme difference in that dog’s long term survival and quality of life,” she emphasized.